Karyopharm Therapeutics
KPTI
KPTI
108 hedge funds and large institutions have $737M invested in Karyopharm Therapeutics in 2018 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 43 increasing their positions, 21 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
108
Holders Change
+20
Holders Change %
+22.73%
% of All Funds
2.48%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.05%
New
32
Increased
43
Reduced
21
Closed
10
Calls
$616K
Puts
$572K
Net Calls
+$44K
Net Calls Change
+$98K
Top Buyers
| 1 |
CCM
Consonance Capital Management
New York
|
+$81M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$24.8M |
| 3 |
State Street
Boston,
Massachusetts
|
+$22.9M |
| 4 |
BlackRock
New York
|
+$22M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$16.7M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$25.4M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$8.77M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
-$7.52M |
| 4 |
Millennium Management
New York
|
-$3.96M |
| 5 |
JPMorgan Chase & Co
New York
|
-$2.85M |
